Markus Bergmann

Markus Bergmann

Company: CureVac SE

Job title: Global Program Head Personalized Cancer Vaccines

Seminars:

Chair’s Opening Remarks 8:55 am

Read more

day: Day One

The mRNA Printer® – A Highly Automated Solution for Agile & Fast Manufacturing of Small-Scale Personalised Therapies 9:00 am

How can transportable and automated printing platforms, such as RNA printers, enable decentralised mRNA production for rapid therapeutic deployment? What role does printing play in creating customised components, such as bioreactor parts and microfluidic devices, to enhance efficiency and reduce material waste in mRNA workflows? How can printed tools, such as improved mixing chambers or…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.